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Abstract

The schwannoma-like pleomorphic adenoma is a rare histopathological variant of the pleomorphic
adenoma. Five previous reports with seven cases exist in English language literature. These tumors
present in the parotid gland most commonly. Intraparotid schwannomas of the facial nerve and
schwannomas with glandular differentiation have also been reported. A 60-year-old male presented
with an asymptomatic swelling over the left angle of the mandible. The swelling had been present for
about 12 years with a recent increase in size. CT imaging showed a hyperdense circumscribed mass of
the superficial lobe of the parotid. The working diagnosis was that of a benign tumor of salivary gland
or soft tissue origin. The mass was excised with careful preservation of the facial nerve. The 3.5 cm

mass was submitted for histopathological examination. The well-circumscribed, encapsulated mass
showed a predominant sheet-like proliferation of Antoni type A-like tissue, Foci of glandular
differentiation with duct-like structures were also seen. Cytological atypia or mitotic activity were not
seen. Nuclei of lesional cells diffusely and strongly expressed reactivity to p63. The final diagnosis was a
schwannoma-like pleomorphic adenoma. No recurrence has been reported in the 15 months since the
removal. Facial nerve function is unimpaired with a House Brackmann facial nerve function score of
one. The potential for misdiagnosis in fine needle aspirate and incisional biopsies is real in cases of
schwannoma-like pleomorphic adenoma. The diagnostic pitfalls include the schwannoma and
leiomyoma. Schwannomas with glandular differentiation have also been reported and therefore a
misdiagnosis may potentially occur in excised specimens. Careful application of immunohistochemistry
may help in the differentiation of these lesions.
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Introduction

Pleomorphic adenomas (PA) account from 40 to 70% of epithelial tumors of salivary glands.
Approximately 80% of PA affect the parotid glands wherein the most common location is the
superficial lobe and the tail of the gland [1]. Triantafyllou et al. correlated the histology, function and
secretions of normal glands to the altered microstructure in a PA. In a tabulation of histological
components of PA, they have alluded to the schwannomatous arrangement of the spindled epithelial
cell component [2]. A Pubmed/MEDLINE electronic database search including phrases such as
“schwannoma-like pleomorphic adenoma”, “schwannoma-like mixed tumor”, “pleomorphic adenoma
palisading” retrieved five papers with a total of seven cases of this rare variant of the PA (Table 1).
Intraparotid schwannomas of the facial nerve have been frequently reported. A Pubmed/MEDLINE
database search using the phrase “intraparotid schwannoma” produced 26 papers in a period from
2010 to 2016, including one case in a horse. To further complicate the diagnostic process,
schwannomas with glandular and pseudoglandular features have also been described [3]. We present a
well-documented case of a schwannoma-like pleomorphic adenoma of the parotid gland and describe
the clinical features, imaging studies, intraoperative findings, histopathology and the
immunohistochemical findings. A brief comparison is made with its potential diagnostic pitfall, the
intraparotid schwannoma. The role of immunohistochemical markers in their differentiation is also
discussed.
Table 1 Demographics and clinical features of cases of pleomorphic adenoma with schwannoma-like
phenotype
Authors
Merino and LiVolsi [4]

Age
74
39

Gender
F
F

Site
Deep lobe, parotid
Parotid (lobe NA)

Duration
5 years
1 year

Takeda and Shimono [5]

62
48
75

M
F
F

Parotid (lobe NA)
Hard palate
Parotid (lobe NA)

10 months
3 months
NA

Kajor et al. [6]

Size
2 cm x 3 cm
1.5 cm
round
NA
NA
3 cm

Symptoms
Asymptomatic
Asymptomatic
Asymptomatic
Asymptomatic
NA

Tille et al. [7]

47

F

Lombardi et al. [8]
Present case

44
60

F
M

Deep lobe, parotid
with
parapharyngeal
extension
Parotid (lobe NA)
Superficial lobe,
Parotid

Symptoms: 3.2 cm
2 months

Pain

3 months
12 years

NA
Asymptomatic

1.5 cm
3.5 cm

NA information is not available. Age range 39–75 years (mean 56.12 years, median 54 years). M:F ratio
1:3

Case Report

A 60-year-old male presented with a mass over the left angle of the mandible (Fig. 1). The mass was
slow growing and asymptomatic. It had been present for approximately 12 years. The patient was
motivated to seek a consult due to a recent increase in size of the mass. The patient was a nonsmoker
and his medical history showed no significant illnesses. The skin over the mass was loose and not
attached to the underlying mass. The mass was freely movable in all planes. The mass felt
circumscribed and firm to palpation. It was non-tender. Regional lymph nodes were not palpable.
Muscles of facial expression were intact. Intraoral examination did not reveal overt mucosal, dental or
periodontal disease. A computed tomography scan revealed a predominantly hyper dense soft tissue
mass with focal internal hypo densities, involving the superficial lobe of the parotid (Fig. 2). The clinical
and radiographic differential diagnosis included benign tumors of salivary gland and soft tissue origin
and lymph node pathology of intra parotid nodes origin. The patient elected to have the mass excised.

Fig. 1 A mass overlying the left angle of the mandible

Fig. 2 CTs (Left coronal, Right axial) show a heterogenous, hyperdense mass with hypodense foci involving the
superficial lobe of the parotid

A superficial parotidectomy was performed. The facial nerve was monitored intraoperatively using a nerve
integrity monitoring system. The mass was found limited to the superficial lobe of the parotid gland (Fig. 3). The
mass did not appear to be in continuity with the nerve bundles. It was removed with a cuff of normal parotid
tissue. The facial nerve and its branches were intact (Fig. 4). The excised tumor measured 3.5 cm in greatest
diameter. The lesion was placed in 10% neutral buffered formalin and submitted for histopathological
examination.

Fig. 3 The mass arose from the superficial lobe of the parotid gland

Fig. 4 Post-resection view showing intact facial nerve and its branches (arrow)
Cross sections of the gross specimen showed a circumscribed dense mass with areas of hemorrhage
and cystic cavitation (Fig. 5). Hematoxylin and eosin stained sections confirmed a well-circumscribed
mass with a collagenous capsule. Areas of intratumoral hemorrhage and cystic cavitation were seen
(Fig. 6). The tumor showed a proliferation of sheets of spindle cells with palisaded nuclei and
eosinophilic Verocay body-like areas. The overall impression was of Antoni type A tissue as in a
schwannoma (Figs. 7, ,8,8, ,11).11). Limited amount of Antoni type B-like tissue mixed with fibrofatty
connective tissue was also seen (Fig. 9). Focal areas of the tumor showed glandular differentiation with
dilated duct-like structures bound by one to two layers of cuboidal to low columnar cells. The ductal
lumen were filled with an amorphous eosinophilic material and few inflammatory cells (Figs. 10,
,11,11, ,13a).13a). Based on the histopathological findings, the differential diagnosis was a
schwannoma with glandular differentiation and areas of ancient change and a schwannoma-like
pleomorphic adenoma.

Fig. 5 Gross specimen sections showing a well-circumscribed dense mass with areas of cystic degeneration and
hemorrhage (arrow)

Fig. 6 A well-circumscribed mass bound by a collagenous capsule containing prominent foci of hemorrhage and
cystic degeneration. H & E 4X

Fig. 7 Mass showing prominent areas of nuclear palisading reminiscent of Antoni A tissue. H & E 10X

Fig. 8 Areas of the tumor showing Antoni A-like tissue with prominent Verocay body-like and hyaline areas. H &
E 10X

Fig. 9 The tumor also showed Antoni B-like areas intermixed with fatty tissue. H & E 4X

Fig. 10 Areas of the lesion showing hemorrhage, hyaline-like collagen and glandular differentiation. H & E 4X

Fig. 11 Confluence of Antoni A-like and Antoni B-like areas and glandular differentiation in the tumor. H & E 10X

Fig. 13 a Photomicrograph showing duct-like glandular areas within tumor (arrow). H & E 10X, b p63 highlights
the myoepithelial cell nuclei. The ductal cells remain negative (arrow). 10X

An S100 stain was of no differentiating use as S100 stains schwann cells and myoepithelial cells. The nuclei of
the spindle cells were diffusely and strongly reactive to p63 (Fig. 12). The nuclei of myoepithelial cells around
the ductal and tubular structures also expressed strong p63 reactivity. The ductal cells remained negative
(Fig. 13b). Based on the immunohistochemical reactivity pattern, a diagnosis of a schwannoma-like pleomorphic
adenoma was given. The circumscribed tumor appeared excised with clear margins (Fig. 6).

Fig. 12 The spindle cells showing diffuse, strong nuclear reactivity to p63. 10X

Post-operative follow-up was uneventful. Facial nerve function was normal with a House-Brackmann
facial nerve function score of one. The most recent follow-up was 15 months post-operatively with no
evidence of recurrent disease.

Discussion

Pleomorphic adenomas are recognized for extreme variation in their microscopic architecture to a
point that almost no two cases are histopathologically alike. This is due to the myriad variations in the
epithelial and mesenchymal-like tissue in these tumors. Efforts to list the various histopathological
components and architectural patterns in the PA have been made in the past [9, 10]. It is likely that
some of the rare, extreme variations of the PA were misdiagnosed solely on the basis of pattern
recognition. Evolution in immunohistochemical techniques has resulted in reclassification of many such
tumors. Triantafyllou et al. in 2015 compiled the most comprehensive listing of histopathological
components in a PA. In this list, they refer to a spindle cell type of an epithelial component with a
schwannomatous arrangement [2]. Only five previous reports accounting for seven cases of a PA with a
schwannomatous phenotype have been described. Table 1 lists the demographic and clinical features
of these previously reported cases. Table 1 is inclusive of our case.
PAs with schwannomatous features were diagnosed across an age range from 39 to 75 years with a
mean of 56.12 years and a median of 54 years. The male to female ratio was 1:3. Seven out of the eight
cases affected the parotid gland and one case affected the hard palate. Two of the seven parotid gland
cases involved the deep lobe. Our case involved the superficial lobe. This information was not available
in four cases. Tumors ranged in size from 1.5 to 3.5 cm. Tumor size was not available in two cases [5].
Lesional duration ranged from 3 months to 12 years. The patient with the deep lobe tumor with
extension into the parapharyngeal space had pain of 2 months duration. It is likely that that this 3.2 cm
tumor was present for a significantly longer period of time [7]. Five other cases were asymptomatic.
This information was available in two cases [6, 8]. Imaging studies were available in three cases
including our case. The tumors were well-defined. The tumor in our case was hyperdense with focal

internal fluid-like hypodensities likely representing areas of cystic degeneration (Fig. 2). All the tumors
were excised with facial nerve preservation. Specific information on management was limited. The
tumor of the deep lobe (case 1) was removed with a subtotal parotidectomy and case 2 was treated
with a partial parotidectomy [4]. The tumor of the deep lobe with parapharyngeal extension was
treated with a total parotidectomy [7]. The tumor in our case was removed with a superficial
parotidectomy.
Histopathologically (Table 2), four of the tumors were encapsulated. This information was not available
in four cases. Schwannomatous areas with nuclear palisading were predominant in five cases [4, 7, 8
and present case]. The tumor in our case also showed cystic degeneration and hemorrhage; findings
that potentially may be interpreted as characterizing “ancient” change in a schwannoma. The ductal
and tubular areas in our case were focal and were also seen at the periphery of the tumor as in the
case reported by Tille et al. [7]. In one case, ductal areas were found following a “prolonged search” [4,
case 2]. Two cases showed predominant conventional PA features including tubules, fibromyxoid and
chondromyxoid areas. Schwannomatous areas were focal [5]. Immunohistochemistry information
(Table 2) was available only in three cases [7, 8 and present case]. p63 was consistent in differentiating
the PA from a schwannoma in these cases. The nuclei of the fusiform and spindle cells in the
schwannoma-like areas were consistently and strongly positive to p63 in our case (Fig. 12) and p63
highlighted only the myoepithelial cells surrounding the ductal/tubular structures (Fig. 13b). While
myoepithelial cells stain with p63 [11, 12], p63 is negative in schwannomas [13]. S100, a marker that is
most useful in the diagnosis of a schwannoma finds no application in its differentiation from a
schwannoma-like PA because S100 also stains myoepithelial cells [11, 14]. Unlike previous two studies
[7, 8], AE1/AE3 pankeratin was not used in this case. A study by Fanburg-Smith et al. showed that
although 22 peripheral schwannomas examined were negative for AE1/AE3 pankeratin, 72/104 (69%)
cases of retroperintoneal schwannomas were positive for AE1/AE3 [15]. CD10 reactivity is focal in a PA
with schwannoma-like features and lends no useful information in its differential diagnosis. 5 of 11
cases (45%) of schwannoma were found to express CD10 [16] and therefore the use of CD10 in
differentiating a PA with schwannoma-like features from a schwannoma is of little practical use.
Similarly, SOX10 (Transcription factor SRY-related HMG-box) that has found application in salivary
gland tumor diagnosis including the PA, is also expressed by schwann cells [17]. Pleomorphic adenoma
gene 1 (PLAG1) nuclear expression is observed in PAs, recurrent PAs and carcinoma-ex-pleomorphic
adenoma [18, 19]. PLAG1 is also expressed in a subset of lipoblastomas, gastrointestinal stromal
tumors, leiomyomas, angiomyofibroblastomas, synovial sarcomas and myxofibrosarcomas. However,
all neural tumors including six schwannomas tested negative [20]; potentially creating a role for PLAG1
in addition to p63, in differentiating a PA with schwannoma-like features from a schwannoma.

Table 2 Histopathological and Immunohistochemical features of cases of pleomorphic adenoma with schwannoma-like features
Authors

Age Gender Capsule

Merino
and LiVolsi
[4]

74

F

Encapsulated Sheets of spindle cells. Some
areas of palisading

39

F

(NA)

62

M

(NA)

Fusiform spindle cells
arranged parallel
Foci of palisading

48
75

F
F

(NA)
FNA cytology

Foci of palisading
NA

47

F

Lombardi
et al. [8]

44

F

Present
case

60

M

Takeda
and
Shimono
[5]
Kajor et al.
[6]
Tille et al.
[7]

Schwannoma-like areas

Conventional PA (nonschwannoma) like areas
Small areas of myxoid tissue
with tubuloacinar structures
and islands of epithelium. E.M:
Myoepithelial cells. Ductal cells
with luminal microvilli
Ductal areas found only after
prolonged search
Tubules, myxoid and “fibrous”
tissue predominate.
Chondromyxoid areas present

Immunohistochemistry

Myxoid areas predominate
NA

NA
NA

Encapsulated Predominant areas of spindle
cells with nuclear palisading
and verocay-like bodies
Encapsulated Predominant (~95%) spindle
cells with Antoni type A areas

Myxoid areas and tubular
structures only at the periphery

p63, CD10 and cytokeratin positive in
both components

Foci (~5%) of tubular areas

Encapsulated Predominant Antoni type A
areas. Many Antoni type Blike areas, cystic
degeneration and
hemorrhage (Ancient
schwannoma-like changes)

Focal ductal and tubular
structures

Pankeratin and S100 strong diffuse
positivity.
p63, CD10 and SMA focal positivity
Strong, diffuse p63 positivity and
focal CD10 positivity.
P63 was positive in the spindle
shaped myoepithelial cells and
myoepithelial cells around ductal /
tubular structures. Ductal cells were
negative

NA

NA
NA

Schwannomas of the facial nerve are more common in the intratemporal location but may also arise in
the parotid gland [21–27]. While intratemporal and internal auditory canal facial nerve schwannomas
may present with neurosensorial hearing loss, tinnitus, progressive facial weakness or paralysis, the
intraparotid facial nerve schwannoma may be entirely asymptomatic with no facial nerve dysfunction.
Also, there are no imaging study findings unique to a intraparotid facial nerve schwannoma. In these
ways, a proportion of intraparotid facial nerve schwannomas are impossible to distinguish from the PA
that is a more common lesion at this location [21–23, 27].
Fine needle aspiration (FNA) biopsies reportedly represent the initial diagnostic modality in a parotid
mass [1]. However, several reports have indicated that FNA has been either inconclusive or have
resulted in a misdiagnosis of a PA in cases of intraparotid facial nerve schwannomas [27–30]. This
ambiguity understandably presents intraoperative and post-operative challenges such as inability to
locate and separate the facial nerve with resulting facial paralysis [27].
Further, this ambiguity is extended histopathologically when PAs show a divergent schwannoma-like
phenotype as demonstrated in our case and previous reports [4–8]. Examples of epithelioid
schwannomas of the parotid gland diagnosed as PAs have also been reported [31]. Schwannomas with
glandular/pseudoglandular differentiation are well recognized and pose an additional challenge to the
histopathologist [32–35]. Myxoid change, cystic areas and intratumoral hemorrhage are not selective
and may be variably encountered in many benign tumors. In the face of such complexity, it is necessary
to rely on immunohistochemical markers for an accurate diagnosis.
Immunohistochemical markers S100, SOX10 and CD10 are unable to differentiate between a PA with
divergent schwannoma-like histology and a schwannoma. p63 appears to consistently differentiate
myoepithelial cells in a PA from a schwannoma. Negative staining of schwannomas with PLAG1 was
studied in only six cases [20]. PLAG1 may potentially find a role in this application similar to p63.
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